These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1269525)
1. Interspecies mouse x Akodon urichi somatic cell hybrids: comparative immunogenicity of parental and hybrid cells. Satya Murthy M; Belehradek J; Barski G Eur J Cancer (1965); 1976 Jan; 12(1):33-9. PubMed ID: 1269525 [No Abstract] [Full Text] [Related]
2. Expression of malignancy in interspecies Chinese hamster X mouse cell hybrids. Barski G; Blanchard MG; Youn JK; Leon B J Natl Cancer Inst; 1973 Sep; 51(3):781-92. PubMed ID: 4355218 [No Abstract] [Full Text] [Related]
3. Induction of tumor cell rejection in the low responsive YAC-lymphoma strain A host combination by immunization with somatic cell hybrids. Klein G; Klein E Eur J Cancer (1965); 1979 Apr; 15(4):551-7. PubMed ID: 436915 [No Abstract] [Full Text] [Related]
4. [Protection afforded by hybrid cells against the inoculation of the parental tumour line (author's transl)]. Favre R; Filipczyk J; Berebbi M; Meyer G Ann Immunol (Paris); 1974; 125(3):491-7. PubMed ID: 4369657 [No Abstract] [Full Text] [Related]
5. Expression of polyoma-induced transplantation antigen in hybrid cell lines. Klein G; Harris H Nat New Biol; 1972 Jun; 237(75):163-4. PubMed ID: 4338519 [No Abstract] [Full Text] [Related]
6. Interspecies Lewis lung carcinoma x Chinese hamster ovary hybrids as protective agents against Lewis lung carcinoma tumor growth. Wolfman J; Baumal R; Marks A Cancer Res; 1985 Dec; 45(12 Pt 1):6341-6. PubMed ID: 4063985 [TBL] [Abstract][Full Text] [Related]
7. Tumor-associated transplantation antigens in immune rejection of mouse malignant cell hybrids. Jami J; Ritz E Proc Natl Acad Sci U S A; 1975 Jun; 72(6):2130-4. PubMed ID: 49053 [TBL] [Abstract][Full Text] [Related]
8. The use of hybrid cells in immunotherapy. Favre R; Carcassonne Y; Meyer G Oncology; 1977; 34(2):84-6. PubMed ID: 197461 [TBL] [Abstract][Full Text] [Related]
9. Immunoprotective capability of somatic hybrid cells in comparison with parental tumor cells maintained in vitro. Mizushima Y; Cohen EP Tohoku J Exp Med; 1985 Apr; 145(4):447-53. PubMed ID: 4024076 [TBL] [Abstract][Full Text] [Related]
10. Loss of anti-tumour immunogenicity of a somatic cell hybrid line with increasing subculture. Favre R; Carcassonne Y; Meyer G Br J Cancer; 1975 Jul; 32(1):139-41. PubMed ID: 169867 [TBL] [Abstract][Full Text] [Related]
11. Tumorigenicity of mouse-human diploid hybrids in nude mice. Croce CM; Aden C; Koprowski H Science; 1975 Dec; 190(4220):1200-2. PubMed ID: 173020 [TBL] [Abstract][Full Text] [Related]
12. Developmental potentialities and surface antigens of mouse teratocarcinoma x lymphoid cell hybrids. Rousset JP; Jami J; Dubois P; Avilès D; Ritz E Somatic Cell Genet; 1980 May; 6(3):419-33. PubMed ID: 7404272 [TBL] [Abstract][Full Text] [Related]
13. Tumor-associated transplantation antigens of myelomas induced in BALB-c mice. Williams WH; Krueger RG J Natl Cancer Inst; 1972 Dec; 49(6):1613-20. PubMed ID: 4119165 [No Abstract] [Full Text] [Related]
14. Cellular and humoral response to immunization with semi-allogeneic hybrid cells in the mouse. Jami J; Rubio N; Ritz E Eur J Cancer (1965); 1976 Jan; 12(1):13-8. PubMed ID: 1269524 [No Abstract] [Full Text] [Related]
15. Immunopotentiation with BCG. 3. Modulation of the response to a tumor-specific antigen. Hawrylko E; Mackaness GB J Natl Cancer Inst; 1973 Nov; 51(5):1677-82. PubMed ID: 4587142 [No Abstract] [Full Text] [Related]
16. Immunopotentiation with BCG. IV. Factors affecting the magnitude of an antitumor response. Hawrylko E; Mackaness GB J Natl Cancer Inst; 1973 Nov; 51(5):1683-8. PubMed ID: 4587143 [No Abstract] [Full Text] [Related]
17. [Characteristics of the antigenic composition of the cells of intra- and interspecific hybrids of murine hepatoma XXIIa]. Aleksanian IuT; Ignatova TN Biull Eksp Biol Med; 1982 Aug; 94(8):77-9. PubMed ID: 7126862 [TBL] [Abstract][Full Text] [Related]
18. Phenotype and surface antigens of mouse teratocarcinoma x fibroblast cell hybrids. Rousset JP; Dubois P; Lasserre C; Avilès D; Fellous M; Jami J Somatic Cell Genet; 1979 Nov; 5(6):739-52. PubMed ID: 545722 [TBL] [Abstract][Full Text] [Related]
19. Nonmalignancy of hybrids derived from two mouse malignant cells. I. Hybrids between L1210 leukemia cells and malignant L cells. Jami J; Ritz E J Natl Cancer Inst; 1973 Nov; 51(5):1647-53. PubMed ID: 4762938 [No Abstract] [Full Text] [Related]
20. Tumorigenicity and tumour-graft rejection of polyoma virus-transformed fibroblast-T-lymphocyte hybrids. Foa C; Berebbi M; Lipcey C; Galindo JR; Bonneau H Br J Exp Pathol; 1982 Jun; 63(3):305-14. PubMed ID: 6284193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]